Table 3.
Characteristic | Adjusted OR (95% CI) |
P Value |
---|---|---|
Age, y | ||
2–4 | Reference group | |
5–9 | 6.4 (3.4–12.1) | <.01 |
10–17 | 10.7 (5.4–21.1) | <.01 |
Hilar lymphadenopathy | 3.1 (1.6–5.8) | <.01 |
Receipt of antibiotics prior to admission within 5 d |
2.3 (1.5–3.5) | <.01 |
Rales | 2.2 (1.5–3.2) | <0.01 |
Codetected pathogens | 2.1 (1.4–3.3) | <.01 |
Headache | 1.6 (1.04–2.5) | .03 |
Sore throat | 1.6 (1.1–2.3) | .03 |
Decreased breath sounds | 1.5 (1.01–2.2) | .04 |
Wheezing (symptom) | 0.6 (.4–.9) | <.01 |
Runny nose | 0.6 (.4–.8) | <.01 |
Study site (Salt Lake City) | 0.5 (.4–.8) | <.01 |
Chest pain | 0.4 (.3–.7) | <.01 |
Abbreviations: CI, confidence interval; OR, odds ratio.
a For this analysis, only children who had specimens tested for both bacteria and viruses were included. Variables that were tested in the model but did not reach significance: sex, clinical presentation of fever/feverish, fatigue, chills, abdominal pain, myalgia, dyspnea, examination findings on presentation: hypoxia, rhonchi, wheezing, chest indrawing, tachypnea, chest retraction; radiographic findings: single and multiple lobar infiltrate, pleural effusion; comorbid condition: chromosomal disorder; household size; interaction between age and codetection.